{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:42:10Z","timestamp":1793317330781,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP15K09130"],"award-info":[{"award-number":["JP15K09130"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K08125"],"award-info":[{"award-number":["JP18K08125"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H03821"],"award-info":[{"award-number":["21H03821"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08143"],"award-info":[{"award-number":["21K08143"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008664","name":"Ono Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015644","name":"JPS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015644","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jphs.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T23:09:48Z","timestamp":1659740988000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7247-1448","authenticated-orcid":false,"given":"Masatsune","family":"Ogura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jphs.2022.07.004_bib1","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1016\/S0021-9258(19)84918-9","article-title":"Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts","volume":"264","author":"Lange","year":"1989","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nchembio.2268","article-title":"Orthogonal lipid sensors identify transbilayer asymmetry of plasma membrane cholesterol","volume":"13","author":"Liu","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib3","first-page":"1","article-title":"PCSK9 inhibition in the management of familial hypercholesterolemia","volume":"71","author":"Ogura","year":"2018","journal-title":"J\u00a0Cardiol"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.13.1","article-title":"ABCA1 and biogenesis of HDL","volume":"13","author":"Yokoyama","year":"2006","journal-title":"J\u00a0Atherosclerosis Thromb"},{"issue":"9","key":"10.1016\/j.jphs.2022.07.004_bib5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1194\/jlr.M300511-JLR200","article-title":"Lipoprotein cholesteryl ester production, transfer, and output in\u00a0vivo in humans","volume":"45","author":"Schwartz","year":"2004","journal-title":"J\u00a0Lipid Res"},{"issue":"Suppl","key":"10.1016\/j.jphs.2022.07.004_bib6","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","volume":"50","author":"Rader","year":"2009","journal-title":"J\u00a0Lipid Res"},{"issue":"6","key":"10.1016\/j.jphs.2022.07.004_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.ATV.8.6.737","article-title":"High density lipoprotein cholesterol and mortality. The Framingham Heart Study","volume":"8","author":"Wilson","year":"1988","journal-title":"Arteriosclerosis"},{"issue":"24","key":"10.1016\/j.jphs.2022.07.004_bib8","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJM199006143222403","article-title":"Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease","volume":"322","author":"Pekkanen","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.jphs.2022.07.004_bib9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Emerging Risk Factors","year":"2009","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.jphs.2022.07.004_bib10","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"9753","key":"10.1016\/j.jphs.2022.07.004_bib12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jphs.2022.07.004_bib13","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jphs.2022.07.004_bib14","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2022.07.004_bib15","doi-asserted-by":"crossref","unstructured":"Schwartz GG, Olsson AG, Abt M, et\u00a0al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med.367(22):2089-2099.","DOI":"10.1056\/NEJMoa1206797"},{"issue":"20","key":"10.1016\/j.jphs.2022.07.004_bib16","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Group","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2022.07.004_bib18","doi-asserted-by":"crossref","unstructured":"Keene D, Price C, Shun-Shin MJ, Francis DP. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ.349:g4379.","DOI":"10.1136\/bmj.g4379"},{"issue":"11","key":"10.1016\/j.jphs.2022.07.004_bib19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease","volume":"45","author":"Do","year":"2013","journal-title":"Nat Genet"},{"issue":"9841","key":"10.1016\/j.jphs.2022.07.004_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jphs.2022.07.004_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"21","key":"10.1016\/j.jphs.2022.07.004_bib22","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jphs.2022.07.004_bib23","doi-asserted-by":"crossref","first-page":"E500","DOI":"10.1210\/jc.2010-0450","article-title":"Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease","volume":"95","author":"Haase","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib24","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1210\/jc.2011-1846","article-title":"LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals","volume":"97","author":"Haase","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jphs.2022.07.004_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.atherosclerosis.2020.02.002","article-title":"Apolipoprotein A-I concentrations and risk of coronary artery disease: a Mendelian randomization study","volume":"299","author":"Karjalainen","year":"2020","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib26","doi-asserted-by":"crossref","first-page":"159063","DOI":"10.1016\/j.bbalip.2021.159063","article-title":"HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease - insights from randomized clinical trials and human genetics","volume":"1867","author":"Kjeldsen","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jphs.2022.07.004_bib27","doi-asserted-by":"crossref","unstructured":"Ko DT, Alter DA, Guo H, et\u00a0al. High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: the CANHEART study. J Am Coll Cardiol.68(19):2073-2083.","DOI":"10.1016\/j.jacc.2016.08.038"},{"key":"10.1016\/j.jphs.2022.07.004_bib28","doi-asserted-by":"crossref","unstructured":"Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J.38(32):2478-2486.","DOI":"10.1093\/eurheartj\/ehx163"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacl.2018.01.014","article-title":"Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: the EPOCH-Japan study","volume":"12","author":"Hirata","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"issue":"Suppl","key":"10.1016\/j.jphs.2022.07.004_bib30","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1194\/jlr.R800034-JLR200","article-title":"The metabolism and anti-atherogenic properties of HDL","volume":"50","author":"Rye","year":"2009","journal-title":"J\u00a0Lipid Res"},{"issue":"5","key":"10.1016\/j.jphs.2022.07.004_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-2275(20)32113-1","article-title":"Cell cholesterol efflux: integration of old and new observations provides new insights","volume":"40","author":"Rothblat","year":"1999","journal-title":"J\u00a0Lipid Res"},{"issue":"5","key":"10.1016\/j.jphs.2022.07.004_bib32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehr103","article-title":"Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein","volume":"33","author":"Hoang","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jphs.2022.07.004_bib33","doi-asserted-by":"crossref","unstructured":"Khera AV, Cuchel M, de la Llera-Moya M, et\u00a0al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med.364(2):127-135.","DOI":"10.1056\/NEJMoa1001689"},{"key":"10.1016\/j.jphs.2022.07.004_bib34","doi-asserted-by":"crossref","unstructured":"Rohatgi A, Khera A, Berry JD, et\u00a0al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med.371(25):2383-2393.","DOI":"10.1056\/NEJMoa1409065"},{"key":"10.1016\/j.jphs.2022.07.004_bib35","doi-asserted-by":"crossref","unstructured":"Saleheen D, Scott R, Javad S, et\u00a0al. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol.3(7):507-513.","DOI":"10.1016\/S2213-8587(15)00126-6"},{"key":"10.1016\/j.jphs.2022.07.004_bib36","doi-asserted-by":"crossref","unstructured":"Ogura M, Hori M, Harada-Shiba M. Association between cholesterol efflux capacity and atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol.36(1):181-188.","DOI":"10.1161\/ATVBAHA.115.306665"},{"key":"10.1016\/j.jphs.2022.07.004_bib37","doi-asserted-by":"crossref","unstructured":"Furuhashi M, Ogura M, Matsumoto M, et\u00a0al. Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages. Sci Rep.7(1):217.","DOI":"10.1038\/s41598-017-00177-w"},{"key":"10.1016\/j.jphs.2022.07.004_bib38","article-title":"Additive effects of drinking habits and a susceptible genetic polymorphism on cholesterol efflux capacity","author":"Matsumoto","year":"2022","journal-title":"J\u00a0Atheroscler Thromb"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pcad.2015.05.004","article-title":"High-density lipoprotein function measurement in human studies: focus on cholesterol efflux capacity","volume":"58","author":"Rohatgi","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.jphs.2022.07.004_bib40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbalip.2018.08.002","article-title":"A\u00a0critical appraisal of the measurement of serum 'cholesterol efflux capacity' and its use as surrogate marker of risk of cardiovascular disease","volume":"1863","author":"Anastasius","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib41","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190213","article-title":"Usefulness of apolipoprotein B-depleted serum in cholesterol efflux capacity assays using immobilized liposome-bound gel beads","volume":"39","author":"Horiuchi","year":"2019","journal-title":"Biosci Rep"},{"issue":"8","key":"10.1016\/j.jphs.2022.07.004_bib42","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201495","article-title":"Comparison of a novel cholesterol efflux assay using immobilized liposome-bound gel beads with the conventional method","volume":"40","author":"Horiuchi","year":"2020","journal-title":"Biosci Rep"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/00045632211054406","article-title":"Novel cholesterol efflux assay using immobilized liposome-bound gel beads: confirmation and improvement for application in clinical laboratory","volume":"59","author":"Horiuchi","year":"2022","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib44","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2011.07.013","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"1821","author":"Alwaili","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jphs.2022.07.004_bib46","doi-asserted-by":"crossref","unstructured":"Agarwala AP, Rodrigues A, Risman M, et\u00a0al. High-density lipoprotein (HDL) phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease. Arterioscler Thromb Vasc Biol.35(6):1515-1519.","DOI":"10.1161\/ATVBAHA.115.305504"},{"issue":"23","key":"10.1016\/j.jphs.2022.07.004_bib47","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st century: a multifunctional roadmap for future HDL research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jphs.2021.11.005","article-title":"ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis","volume":"148","author":"Matsuo","year":"2022","journal-title":"J\u00a0Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib50","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5551\/jat.20909","article-title":"High-density lipoprotein levels have markedly increased over the past twenty years in Japan","volume":"21","author":"Yokoyama","year":"2014","journal-title":"J\u00a0Atherosclerosis Thromb"},{"key":"10.1016\/j.jphs.2022.07.004_bib53","unstructured":"Assmann G, von Eckardstein A, Brewer HBJ. Familial analphalipoproteinemia: tangier disease. The online Metabolic and molecular Bases of inherited disease. New York: McGraw-Hill Medical:DOI: 10.1036\/ommbid.1151."},{"issue":"10","key":"10.1016\/j.jphs.2022.07.004_bib54","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.5551\/jat.43257","article-title":"Accelerated atherogenicity in tangier disease","volume":"25","author":"Muratsu","year":"2018","journal-title":"J\u00a0Atherosclerosis Thromb"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib55","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jocn.2005.07.009","article-title":"Paranodal pathology in Tangier disease with remitting-relapsing multifocal neuropathy","volume":"13","author":"Cai","year":"2006","journal-title":"J\u00a0Clin Neurosci"},{"issue":"8","key":"10.1016\/j.jphs.2022.07.004_bib56","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.97.8.4245","article-title":"High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1","volume":"97","author":"McNeish","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.jphs.2022.07.004_bib57","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI10727","article-title":"Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes","volume":"106","author":"Clee","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.jphs.2022.07.004_bib58","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/01.ATV.20.8.1983","article-title":"Common and rare ABCA1 variants affecting plasma HDL cholesterol","volume":"20","author":"Wang","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCGENETICS.110.957563","article-title":"Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol","volume":"4","author":"Edmondson","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"10.1016\/j.jphs.2022.07.004_bib61","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1172\/JCI200523915","article-title":"Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of ApoA-I","volume":"115","author":"Timmins","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib62","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI27352","article-title":"Intestinal ABCA1 directly contributes to HDL biogenesis in\u00a0vivo","volume":"116","author":"Brunham","year":"2006","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.jphs.2022.07.004_bib63","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI200112810","article-title":"Monocyte\/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels","volume":"108","author":"Haghpassand","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.012587699","article-title":"The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL\/6 and apoE-knockout mice","volume":"99","author":"Joyce","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI0215748","article-title":"Increased ABCA1 activity protects against atherosclerosis","volume":"110","author":"Singaraja","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib66","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/01.ATV.0000014804.35824.DA","article-title":"Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages","volume":"22","author":"Aiello","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.jphs.2022.07.004_bib67","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Yvan-Charvet","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib68","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.ATV.0000208364.22732.16","article-title":"Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice","volume":"26","author":"Van Eck","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib69","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cvr\/cvq204","article-title":"Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis","volume":"88","author":"Feng","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib70","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/ATVBAHA.108.182303","article-title":"Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis","volume":"29","author":"Brunham","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.jphs.2022.07.004_bib71","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/ATVBAHA.112.301110","article-title":"Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis","volume":"33","author":"Bi","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib72","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmg.40.3.163","article-title":"A\u00a0common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia","volume":"40","author":"Cenarro","year":"2003","journal-title":"J\u00a0Med Genet"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcad.2016.08.006","article-title":"Diagnosis and treatment of high density lipoprotein deficiency","volume":"59","author":"Schaefer","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.jphs.2022.07.004_bib74","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.jphs.2022.07.004_bib75","doi-asserted-by":"crossref","first-page":"11019","DOI":"10.1074\/jbc.M111041200","article-title":"Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors","volume":"277","author":"Joseph","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/acsptsci.0c00149","article-title":"Discovery of nonlipogenic ABCA1 inducing compounds with potential in Alzheimer's disease and type 2 diabetes","volume":"4","author":"Ben Aissa","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib77","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A\u00a0PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.jphs.2022.07.004_bib78","doi-asserted-by":"crossref","unstructured":"Ozasa H, Ayaori M, Iizuka M, et\u00a0al. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1\/ABCG1 expressions via PPARgamma\/LXRalpha pathway: findings from in\u00a0vitro and ex\u00a0vivo studies. Atherosclerosis.219(1):141-150.","DOI":"10.1016\/j.atherosclerosis.2011.07.113"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.RES.0000053386.46813.E9","article-title":"Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages","volume":"92","author":"Chinetti","year":"2003","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib80","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.ASN.0000050414.52908.DA","article-title":"PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway","volume":"14","author":"Ruan","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2022.07.004_bib81","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2016.03.003","article-title":"The novel selective PPARalpha modulator (SPPARMalpha) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis","volume":"249","author":"Hennuyer","year":"2016","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jphs.2022.07.004_bib82","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jacl.2018.06.010","article-title":"Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia","volume":"12","author":"Yamashita","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jphs.2022.07.004_bib83","doi-asserted-by":"crossref","first-page":"g4379","DOI":"10.1136\/bmj.g4379","article-title":"Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients","volume":"349","author":"Keene","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jphs.2022.07.004_bib84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2018.09.011","article-title":"Rationale and design of the pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes (PROMINENT) study","volume":"206","author":"Pradhan","year":"2018","journal-title":"Am Heart J"},{"issue":"25","key":"10.1016\/j.jphs.2022.07.004_bib85","doi-asserted-by":"crossref","first-page":"22426","DOI":"10.1074\/jbc.M202996200","article-title":"Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation","volume":"277","author":"Arakawa","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib86","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI200316808","article-title":"A\u00a0PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by ApoA-I","volume":"111","author":"Wang","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.jphs.2022.07.004_bib87","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/ATVBAHA.111.228478","article-title":"Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in\u00a0vitro and in\u00a0vivo","volume":"31","author":"Ogura","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.jphs.2022.07.004_bib88","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1074\/jbc.M109977200","article-title":"Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1","volume":"277","author":"Wang","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"44","key":"10.1016\/j.jphs.2022.07.004_bib89","doi-asserted-by":"crossref","first-page":"41835","DOI":"10.1074\/jbc.M204923200","article-title":"Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux","volume":"277","author":"See","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"48","key":"10.1016\/j.jphs.2022.07.004_bib90","doi-asserted-by":"crossref","first-page":"47890","DOI":"10.1074\/jbc.M306258200","article-title":"Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly","volume":"278","author":"Yamauchi","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.jphs.2022.07.004_bib91","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1074\/jbc.M312571200","article-title":"Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol","volume":"279","author":"Tang","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.jphs.2022.07.004_bib92","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1194\/jlr.M600437-JLR200","article-title":"Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway","volume":"48","author":"Wang","year":"2007","journal-title":"J\u00a0Lipid Res"},{"issue":"20","key":"10.1016\/j.jphs.2022.07.004_bib93","doi-asserted-by":"crossref","first-page":"14868","DOI":"10.1074\/jbc.M611230200","article-title":"Enhanced ApoA-I-dependent cholesterol efflux by ABCA1 from sphingomyelin-deficient Chinese hamster ovary cells","volume":"282","author":"Nagao","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"5985","key":"10.1016\/j.jphs.2022.07.004_bib94","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"Najafi-Shoushtari","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib95","first-page":"674","article-title":"Up-regulated miR-93 contributes to coronary atherosclerosis pathogenesis through targeting ABCA1","volume":"8","author":"He","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOL.0000000000000420","article-title":"MicroRNAs and lipid metabolism","volume":"28","author":"Aryal","year":"2017","journal-title":"Curr Opin Lipidol"},{"issue":"40","key":"10.1016\/j.jphs.2022.07.004_bib97","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1073\/pnas.1008499107","article-title":"MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in\u00a0vivo","volume":"107","author":"Horie","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.jphs.2022.07.004_bib98","doi-asserted-by":"crossref","first-page":"e003376","DOI":"10.1161\/JAHA.112.003376","article-title":"MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-\/- mice","volume":"1","author":"Horie","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"7369","key":"10.1016\/j.jphs.2022.07.004_bib99","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","article-title":"Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides","volume":"478","author":"Rayner","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jphs.2022.07.004_bib100","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCRESAHA.118.314415","article-title":"Specific disruption of Abca1 targeting largely mimics the effects of miR-33 knockout on macrophage cholesterol efflux and atherosclerotic plaque development","volume":"124","author":"Price","year":"2019","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib101","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2337\/dc09-1562","article-title":"Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction","volume":"33","author":"Vergeer","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOL.0000000000000253","article-title":"Apolipoprotein A-I interactions with insulin secretion and production","volume":"27","author":"Rye","year":"2016","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdiacomp.2017.09.012","article-title":"AGE-albumin enhances ABCA1 degradation by ubiquitin-proteasome and lysosomal pathways in macrophages","volume":"32","author":"Iborra","year":"2018","journal-title":"J\u00a0Diabet Complicat"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib104","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jphs.2022.07.004_bib105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.jphs.2022.07.004_bib106","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1161\/ATVBAHA.119.313253","article-title":"Anti-inflammatory effects of HDL (High-Density lipoprotein) in macrophages predominate over proinflammatory effects in atherosclerotic plaques","volume":"39","author":"Fotakis","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"43","key":"10.1016\/j.jphs.2022.07.004_bib107","first-page":"3007","article-title":"Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk","volume":"36","author":"Zewinger","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/clinchem\/hvaa148","article-title":"HDL in morbidity and mortality: a 40+ year perspective","volume":"67","author":"Tall","year":"2021","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.jphs.2022.07.004_bib109","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/HCO.0000000000000508","article-title":"HDLs and the pathogenesis of atherosclerosis","volume":"33","author":"Schwertani","year":"2018","journal-title":"Curr Opin Cardiol"},{"issue":"16","key":"10.1016\/j.jphs.2022.07.004_bib110","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.0912702107","article-title":"Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.jphs.2022.07.004_bib111","doi-asserted-by":"crossref","first-page":"e79848","DOI":"10.1371\/journal.pone.0079848","article-title":"Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study","volume":"8","author":"Merle","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jphs.2022.07.004_bib112","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1167\/iovs.10-7070","article-title":"Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration","volume":"52","author":"Yu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"17","key":"10.1016\/j.jphs.2022.07.004_bib113","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120824","article-title":"Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss","volume":"3","author":"Ban","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jphs.2022.07.004_bib114","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45100","article-title":"Impaired ABCA1\/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration","volume":"8","author":"Storti","year":"2019","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.jphs.2022.07.004_bib115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metabol"},{"issue":"13","key":"10.1016\/j.jphs.2022.07.004_bib116","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1220703110","article-title":"ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging","volume":"110","author":"Nagata","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib117","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/s41598-018-24428-6","article-title":"Temporary sequestration of cholesterol and phosphatidylcholine within extracellular domains of ABCA1 during nascent HDL generation","volume":"8","author":"Ishigami","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jphs.2022.07.004_bib118","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41598-019-39973-x","article-title":"Changes in the asymmetric distribution of cholesterol in the plasma membrane influence streptolysin O pore formation","volume":"9","author":"Ogasawara","year":"2019","journal-title":"Sci Rep"},{"issue":"23","key":"10.1016\/j.jphs.2022.07.004_bib119","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1002\/1873-3468.13945","article-title":"ABC proteins in evolution","volume":"594","author":"Ogasawara","year":"2020","journal-title":"FEBS Lett"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:02:47Z","timestamp":1761163367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861322000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1347861322000548"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2022.07.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}